Related Experiment Videos
Simultaneous presentation of coeliac disease and ulcerative colitis in a child
1Department of Paediatrics, Christchurch Hospital, New Zealand.
Insights
Coeliac disease and inflammatory bowel disease (IBD) are uncommon together in children. This case highlights the importance of considering both conditions during diagnosis and management of pediatric IBD.
Area of Science:
- Pediatric Gastroenterology
- Autoimmune Disorders
- Gastrointestinal Diseases
Background:
- Coeliac disease and inflammatory bowel disease (IBD) are distinct gastrointestinal conditions.
- While individually prevalent in children, their co-occurrence is exceptionally rare.
- Understanding the interplay between these autoimmune conditions is crucial for effective pediatric care.
Observation:
- A rare case of a 7-year-old girl presenting with both coeliac disease and IBD is detailed.
- This combined presentation challenges typical diagnostic and management paradigms.
- The case underscores the need for vigilance in pediatric autoimmune gastrointestinal disorders.
Findings:
- The study presents a unique pediatric case of concurrent coeliac disease and IBD.
- Literature review confirms the rarity of this dual diagnosis in children.
- Diagnostic and therapeutic strategies for co-occurring conditions require careful consideration.
Implications:
- Clinicians should consider screening for coeliac disease in children with IBD, especially during diagnosis, relapse, or treatment resistance.
- Early identification of coeliac disease in IBD patients can optimize management and improve outcomes.
- Serum antibody testing may serve as a valuable screening tool for this rare comorbidity.
Abstract:
Coeliac disease and inflammatory bowel disease (IBD) individually are not uncommon in children, but the occurrence of both conditions together is rare. The combined presentation of coeliac disease and IBD in a girl of 7 years is presented with a review of the related literature. The occurrence of coeliac disease with IBD should be considered at the time of diagnosis and at relapse, or where there is difficulty maintaining remission in established IBD. Screening with serum antibody tests may be helpful.